Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studies
American Journal of Epidemiology · 2026
DOI: 10.1093/aje/kwaf221 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2026. Verfasst von Kristina L Bajema und 13 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs Portland Health Care System, Portland, OR, United States. Hauptthemen laut MEDLINE: Antiviral Agents, Ritonavir, COVID-19 Drug Treatment, Observational Studies as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: HSRD VA, VA HSR, US Food and Drug Administration.
Abstract (Originalsprache)
In a well-designed clinical trial, time zero is when eligibility is determined, treatment is assigned, follow-up time begins, and each of these elements is aligned. Attaining this alignment can be challenging in observational studies, risking potential bias. We compared the impact of different time zero designations on the estimated effectiveness of nirmatrelvir-ritonavir for COVID-19. We identified US veterans who tested positive for SARS-CoV-2 from April 2022 to March 2023 and compared nirmatrelvir-ritonavir vs no treatment using 5 time zero approaches: (1a) test-date (treated) vs test-date (untreated) allowing treatment on days 0-5 with matching, (1b) day 0 only with matching, or (1c) days 0-5 with a clone-censor-weight method; (2) treatment date vs test-date with matching; or (3) treatment date vs matched index date. Thirty-day incidence of hospitalization or death was lower in the nirmatrelvir-ritonavir group than the no treatment group for all time zero approaches. Estimated risk differences (95% CI) were larger for approaches 1a (−2.10% [−2.35 to −1.86]), 1b (−2.03% [−2.40 to −1.84]), and 2 (−2.26% [−2.47 to −2.02]); −1.80% (−1.89 to −1.45) for approach 3; and lowest for approach 1c (−0.95% [−1.11 to −0.75]). Different time zero designations can influence effect estimates and should be carefully considered when designing pharmacoepidemiology studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterans Affairs Portland Health Care System, Portland, OR, United States.
- Division of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland, OR, United States.
- Veterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center (CSP CERC), Veterans Affairs Connecticut Health Care System, West Haven, CT, United States.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT, United States.
- Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States.
- Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, United States.
ORCID-Profile: Kristina L Bajema, Lei Yan, Kristin Berry, David Bui, Hung-Mo Lin, Yuan Huang, Matthew L Maciejewski, Valerie A Smith, Denise M Hynes, George N Ioannou
Förderung
- HSRD VA
- VA HSR
- US Food and Drug Administration
- US Department of Veterans Affairs Cooperative Studies Program and funded in part by the Department of Health and Human Services, Biomedical Advanced Research a…
Zitieren
APA
Bajema, K. L., Yan, L., Berry, K., Bui, D., Lin, H. M., Huang, Y., Li, Y., Rajeevan, N., Maciejewski, M. L., Smith, V. A., Bohnert, A. S. B., Hynes, D. M., Aslan, M., & Ioannou, G. N. (2026). Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studies. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf221
Vancouver
Bajema KL, Yan L, Berry K, Bui D, Lin HM, Huang Y, et al. Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studies. American Journal of Epidemiology. 2026. doi:10.1093/aje/kwaf221
BibTeX
@article{Bajema2026,
author = {Bajema, Kristina L and Yan, Lei and Berry, Kristin and Bui, David and Lin, Hung-Mo and Huang, Yuan and Li, Yuli and Rajeevan, Nallakkandi and Maciejewski, Matthew L and Smith, Valerie A and Bohnert, Amy S B and Hynes, Denise M and Aslan, Mihaela and Ioannou, George N},
title = {Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studies},
journal = {American Journal of Epidemiology},
year = {2026},
doi = {10.1093/aje/kwaf221}
}
EUVIMED